| The multifunctional FUS, EWS and TAF15 proto-oncoproteins show cell type-specific expression patterns and involvement in cell spreading and stress response MK Andersson, A Ståhlberg, Y Arvidsson, A Olofsson, H Semb, ... BMC cell biology 9, 1-17, 2008 | 393 | 2008 |
| New tricks from an old oncogene: Gene fusion and copy number alterations of MYB in human cancer G Stenman, MK Andersson, Y Andrén Cell Cycle 9 (15), 3058-3067, 2010 | 192 | 2010 |
| Distinct cytoplasmic and nuclear functions of the stress induced protein DDIT3/CHOP/GADD153 A Jauhiainen, C Thomsen, L Strömbom, P Grundevik, C Andersson, ... PloS one 7 (4), e33208, 2012 | 137 | 2012 |
| Diagnostic and therapeutic implications of new molecular biomarkers in salivary gland cancers G Stenman, F Persson, MK Andersson Oral oncology 50 (8), 683-690, 2014 | 126 | 2014 |
| The myxoid liposarcoma FUS-DDIT3 fusion oncoprotein deregulates NF-κB target genes by interaction with NFKBIZ M Göransson, MK Andersson, C Forni, A Ståhlberg, C Andersson, ... Oncogene 28 (2), 270-278, 2009 | 91 | 2009 |
| Targeting the oncogenic transcriptional regulator MYB in adenoid cystic carcinoma by inhibition of IGF1R/AKT signaling MK Andersson, MK Afshari, Y Andrén, MJ Wick, G Stenman JNCI: Journal of the National Cancer Institute 109 (9), djx017, 2017 | 85 | 2017 |
| The landscape of gene fusions and somatic mutations in salivary gland neoplasms–implications for diagnosis and therapy MK Andersson, G Stenman Oral oncology 57, 63-69, 2016 | 57 | 2016 |
| Monensin, a novel potent MYB inhibitor, suppresses proliferation of acute myeloid leukemia and adenoid cystic carcinoma cells MV Yusenko, A Trentmann, MK Andersson, LA Ghani, A Jakobs, MFA Paz, ... Cancer Letters 479, 61-70, 2020 | 53 | 2020 |
| Amyloid precursor-like protein 1 is differentially upregulated in neuroendocrine tumours of the gastrointestinal tract Y Arvidsson, E Andersson, A Bergström, MK Andersson, G Altiparmak, ... Endocrine-related cancer 15 (2), 569-581, 2008 | 48 | 2008 |
| Mutation profiling of adenoid cystic carcinomas from multiple anatomical sites identifies mutations in the RAS pathway, but no KIT mutations D Wetterskog, PM Wilkerson, DN Rodrigues, MB Lambros, K Fritchie, ... Histopathology 62 (4), 543-550, 2013 | 45 | 2013 |
| ATR is a MYB regulated gene and potential therapeutic target in adenoid cystic carcinoma MK Andersson, G Mangiapane, PT Nevado, A Tsakaneli, T Carlsson, ... Oncogenesis 9 (1), 5, 2020 | 44 | 2020 |
| Gastrointestinal stromal tumors regularly express synaptic vesicle proteins: evidence of a neuroendocrine phenotype P Bumming, O Nilsson, H Ahlman, A Welbencer, MK Andersson, ... Endocrine-related cancer 14 (3), 853-863, 2007 | 44 | 2007 |
| Overexpression of MYB drives proliferation of CYLD‐defective cylindroma cells N Rajan, MK Andersson, N Sinclair, A Fehr, K Hodgson, CJ Lord, ... The Journal of pathology 239 (2), 197-205, 2016 | 42 | 2016 |
| Differentiation and histogenesis of syringomatous tumour of the nipple and low‐grade adenosquamous carcinoma: evidence for a common origin W Boecker, G Stenman, T Loening, MK Andersson, HP Sinn, P Barth, ... Histopathology 65 (1), 9-23, 2014 | 33 | 2014 |
| IGF2/IGF1R signaling as a therapeutic target in MYB-positive adenoid cystic carcinomas and other fusion gene-driven tumors MK Andersson, P Åman, G Stenman Cells 8 (8), 913, 2019 | 32 | 2019 |
| p37δ is a new isoform of PI3K p110δ that increases cell proliferation and is overexpressed in tumors S Fransson, A Uv, H Eriksson, MK Andersson, Y Wettergren, M Bergo, ... Oncogene 31 (27), 3277-3286, 2012 | 27 | 2012 |
| DDIT3/CHOP and the sarcoma fusion oncoprotein FUS-DDIT3/TLS-CHOP bind cyclin-dependent kinase 2 C Bento, MK Andersson, P Åman BMC cell biology 10, 1-7, 2009 | 27 | 2009 |
| Nuclear expression of FLT1 and its ligand PGF in FUS-DDIT3 carrying myxoid liposarcomas suggests the existence of an intracrine signaling loop MK Andersson, M Göransson, A Olofsson, C Andersson, P Åman BMC cancer 10, 1-10, 2010 | 26 | 2010 |
| K5/K14-positive cells contribute to salivary gland-like breast tumors with myoepithelial differentiation W Boecker, G Stenman, T Loening, MK Andersson, A Bankfalvi, ... Modern Pathology 26 (8), 1086-1100, 2013 | 25 | 2013 |
| Proliferation of Ewing sarcoma cell lines is suppressed by the receptor tyrosine kinase inhibitors gefitinib and vandetanib MK Andersson, P Åman Cancer Cell International 8, 1-6, 2008 | 25 | 2008 |
Göran StenmanProfessor, Sahlgrenska Center for Cancer Research, University of GothenburgVerified email at gu.se
